N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (BioDeep_00000180667)

   

human metabolite blood metabolite


代谢物信息卡片


N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, (R)-isomer

化学式: C12H17NO2 (207.12592220000002)
中文名称: N-甲基-1-(3,4-亚甲二氧基苯基)-2-丁胺
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCC(CC1=CC2=C(C=C1)OCO2)NC
InChI: InChI=1S/C12H17NO2/c1-3-10(13-2)6-9-4-5-11-12(7-9)15-8-14-11/h4-5,7,10,13H,3,6,8H2,1-2H3

描述信息

同义名列表

7 个代谢物同义名

N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, (R)-isomer; N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, (S)-isomer; [1-(2H-1,3-benzodioxol-5-yl)butan-2-yl](methyl)amine; N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine; N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine; 1,3-Benzodioxolyl-N-methylbutanamine; methylbenzodioxolylbutanamine



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Markus R Meyer, Frank T Peters, Hans H Maurer. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicology letters. 2009 Oct; 190(1):54-60. doi: 10.1016/j.toxlet.2009.06.866. [PMID: 19576971]
  • Kei Zaitsu, Munehiro Katagi, Hiroe T Kamata, Tooru Kamata, Noriaki Shima, Akihiro Miki, Hitoshi Tsuchihashi, Yasushige Mori. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic science international. 2009 Jul; 188(1-3):131-9. doi: 10.1016/j.forsciint.2009.04.001. [PMID: 19406592]
  • Adriaan A S Marais, Johannes B Laurens. Rapid GC-MS confirmation of amphetamines in urine by extractive acylation. Forensic science international. 2009 Jan; 183(1-3):78-86. doi: 10.1016/j.forsciint.2008.10.021. [PMID: 19081690]
  • T Montgomery, C Buon, S Eibauer, P J Guiry, A K Keenan, G J McBean. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines. British journal of pharmacology. 2007 Dec; 152(7):1121-30. doi: 10.1038/sj.bjp.0707473. [PMID: 17891159]
  • Ruri Kikura-Hanajiri, Maiko Kawamura, Kazuhiro Saisho, Yukio Kodama, Yukihiro Goda. The disposition into hair of new designer drugs; methylone, MBDB and methcathinone. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Aug; 855(2):121-6. doi: 10.1016/j.jchromb.2007.05.018. [PMID: 17604703]
  • Marjorie Chèze, Marc Deveaux, Claire Martin, Michel Lhermitte, Gilbert Pépin. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake. Forensic science international. 2007 Aug; 170(2-3):100-4. doi: 10.1016/j.forsciint.2007.02.033. [PMID: 17629643]
  • Elke Raes, Alain G Verstraete. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). Journal of analytical toxicology. 2005 Oct; 29(7):632-6. doi: 10.1093/jat/29.7.632. [PMID: 16419392]
  • Toshiaki Nagai, Kazumi Matsushima, Atsuko Suzuki, Atsuko Saotome, Akira Kurosu, Hirohisa Nihei, Kazumi Kuroyanagi, Shogo Tokudome. Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine. Journal of analytical toxicology. 2002 Mar; 26(2):104-9. doi: 10.1093/jat/26.2.104. [PMID: 11916012]
  • F Sadeghipour, J L Veuthey. Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection. Journal of chromatography. A. 1997 Nov; 787(1-2):137-43. doi: 10.1016/s0021-9673(97)00817-0. [PMID: 9409000]
  • P Kintz. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration. Journal of analytical toxicology. 1997 Nov; 21(7):570-5. doi: 10.1093/jat/21.7.570. [PMID: 9399128]
  • P Kintz, C Giroud. Immunoassay responses of MBDB. Journal of analytical toxicology. 1997 Nov; 21(7):589-90. doi: NULL. [PMID: 9399133]
  • Q Li, I Murakami, S Stall, A D Levy, M S Brownfield, D E Nichols, L D Van de Kar. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA). The Journal of pharmacology and experimental therapeutics. 1996 Dec; 279(3):1261-7. doi: NULL. [PMID: 8968349]
  • R Kronstrand. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users. Journal of analytical toxicology. 1996 Oct; 20(6):512-6. doi: 10.1093/jat/20.6.512. [PMID: 8889691]